We previously demonstrated that TrkB activation induced EMT and invasion in animal models of OCSCC, and other studies indicate that TrkB overexpression directly mediates the metastatic phenotype in murine tail-vein and subcutaneous models of cancer progression [26, 27]. The gene discussed is NTRK2; the disease is cancer.